933 related articles for article (PubMed ID: 17161038)
1. Single-photon emission computed tomography/computed tomography in brain tumors.
Schillaci O; Filippi L; Manni C; Santoni R
Semin Nucl Med; 2007 Jan; 37(1):34-47. PubMed ID: 17161038
[TBL] [Abstract][Full Text] [Related]
2. Single-photon emission computed tomography/computed tomography in lung cancer and malignant lymphoma.
Schillaci O
Semin Nucl Med; 2006 Oct; 36(4):275-85. PubMed ID: 16950145
[TBL] [Abstract][Full Text] [Related]
3. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis.
Ingui CJ; Shah NP; Oates ME
Clin Nucl Med; 2006 Nov; 31(11):665-72. PubMed ID: 17053381
[TBL] [Abstract][Full Text] [Related]
4. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
[TBL] [Abstract][Full Text] [Related]
5. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
6. Single-photon emission computed tomography/computed tomographyfor sentinel node mapping in breast cancer.
Husarik DB; Steinert HC
Semin Nucl Med; 2007 Jan; 37(1):29-33. PubMed ID: 17161037
[TBL] [Abstract][Full Text] [Related]
7. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
Sodee DB; Sodee AE; Bakale G
Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
[TBL] [Abstract][Full Text] [Related]
8. Single-photon emission computed tomography/computed tomography in abdominal diseases.
Schillaci O; Filippi L; Danieli R; Simonetti G
Semin Nucl Med; 2007 Jan; 37(1):48-61. PubMed ID: 17161039
[TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of fusion of 131I SPECT and CT images in patients with differentiated thyroid carcinoma.
Yamamoto Y; Nishiyama Y; Monden T; Matsumura Y; Satoh K; Ohkawa M
J Nucl Med; 2003 Dec; 44(12):1905-10. PubMed ID: 14660715
[TBL] [Abstract][Full Text] [Related]
10. Fusion imaging in nuclear medicine--applications of dual-modality systems in oncology.
Schillaci O; Simonetti G
Cancer Biother Radiopharm; 2004 Feb; 19(1):1-10. PubMed ID: 15068606
[TBL] [Abstract][Full Text] [Related]
11. Image fusion analysis of (99m)Tc-HYNIC-Tyr(3)-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours.
Gabriel M; Hausler F; Bale R; Moncayo R; Decristoforo C; Kovacs P; Virgolini I
Eur J Nucl Med Mol Imaging; 2005 Dec; 32(12):1440-51. PubMed ID: 16133384
[TBL] [Abstract][Full Text] [Related]
12. Recurrent cerebral gliomas in MRI and Iodine-123[corrected]-alpha-methyl-tyrosine SPECT: the use of digitally fused images.
Grzelak P; Górska-Chrzastek M; Gajewicz W; Kuśmierek J; Tybor K; Stefańczyk L
Nucl Med Rev Cent East Eur; 2005; 8(2):94-9. PubMed ID: 16437393
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of SPECT/CT with a hybrid camera for the functional anatomical mapping of primary brain tumors by [Tc99m] tetrofosmin.
Filippi L; Schillaci O; Santoni R; Manni C; Danieli R; Simonetti G
Cancer Biother Radiopharm; 2006 Feb; 21(1):41-8. PubMed ID: 16480330
[TBL] [Abstract][Full Text] [Related]
14. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract][Full Text] [Related]
15. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
[TBL] [Abstract][Full Text] [Related]
16. [Fusion of SPECT with computed tomography or magnetic resonance for the interpretation of abnormal tracer uptake].
Aqueveque A C; González E P; Gutiérrez B D; Jaimovich F R; Díaz P JC; Csendes G P; Orellana P P; Lavados M H; Alliende G I; Araya L S
Rev Med Chil; 2007 Jun; 135(6):725-34. PubMed ID: 17728898
[TBL] [Abstract][Full Text] [Related]
17. Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions.
Delbeke D; Schöder H; Martin WH; Wahl RL
Semin Nucl Med; 2009 Sep; 39(5):308-40. PubMed ID: 19646557
[TBL] [Abstract][Full Text] [Related]
18. Optimized scintigraphic evaluation of infection and inflammation: role of single-photon emission computed tomography/computed tomography fusion imaging.
Bunyaviroch T; Aggarwal A; Oates ME
Semin Nucl Med; 2006 Oct; 36(4):295-311. PubMed ID: 16950147
[TBL] [Abstract][Full Text] [Related]
19. Neuronuclear assessment of patients with epilepsy.
Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
[TBL] [Abstract][Full Text] [Related]
20. Behaviors of cost functions in image registration between 201Tl brain tumor single-photon emission computed tomography and magnetic resonance images.
Soma T; Takaki A; Teraoka S; Ishikawa Y; Murase K; Koizumi K
Ann Nucl Med; 2008 Nov; 22(9):825-32. PubMed ID: 19039563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
